Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
Yenisey
C
C
Department of Biochemistry, Adnan Menderes University, Faculty of Medicine, Aydin, Turkey.
Güner
G
G
D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology*; D018394:CA-125 Antigen / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood* / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; C057387:mucinous carcinoma-associated antigen